Form 4: Andrew Slavitt Executes Stock Option and Reports Beneficial Ownership Changes in NeueHealth, Inc.

Director Andrew Slavitt reports exercising stock options and changes in beneficial ownership of NeueHealth, Inc. shares.

Summary

• On May 13, 2025, Andrew Slavitt, a director of NeueHealth, Inc., executed restricted stock units, receiving 10,500 shares of common stock.
• The transaction involved the vesting of restricted stock units, each representing a contingent right to receive one share of NeueHealth's common stock.
• Following the transaction, Slavitt directly owns 18,529 shares of common stock.
• Slavitt also indirectly owns 5,625 shares through Slavitt Holdings LLC, 52,969 shares through Town Hall Ventures LP, and 30,687 shares through Town Hall Ventures II LP.
• Slavitt disclaims beneficial ownership of shares held by Town Hall Ventures LP and Town Hall Ventures II LP except to the extent of his pecuniary interest therein.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, so the sentiment is neutral.

Industry Context

This filing is a routine disclosure related to insider transactions and beneficial ownership, which is standard practice for publicly traded companies. It provides transparency to investors regarding the holdings and transactions of company insiders.

Stakeholder Impact

• The filing provides transparency to shareholders regarding insider transactions.

Key Dates

Keywords

beneficial ownership, Form 4, NeueHealth, Slavitt, stock options, restricted stock units, director, NEUE